Cognitive performance and narrative discourse after SARS-CoV-2 infection
Franklim Oliveira Souza; Nathália Monteiro Santos; Pablo Jordão Alcântara Cruz; Carla Patrícia Hernandez Alves Ribeiro Cesar; Rafael Ciro Marques Cavalcante; Franciely Oliveira de Andrade Santos; Kelly da Silva; Raphaela Barroso Guedes Granzotti
Abstract
Keywords
Referencias
1. Giusti L, Mammarella S, Salza A, Del Vecchio S, Ussorio D, Casacchia M et al. Predictors of academic performance during the COVID-19 outbreak: Impact of distance education on mental health, social cognition and memory abilities in an Italian university student sample. BMC Psychol. 2021;9(1):1-17.
2. Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis - A review of current methods. Biosens Bioelectron. 2021;172(1):112752.
3. Martora F, Fabbrocini G, Nappa P, Megna M. COVID-19 and cutaneous manifestations: A review of the published literature. J Cosmet Dermatol. 2023;22(1):4-10.
4. World Health Organization - WHO [webpage on the internet]. Coronavirus (COVID-19) Dashboard 2024 Jan 18 [accessed on 2024 jan 18]. Available at:
5. Orellana JDY, Marrero L, Horta BL. Letalidade hospitalar por COVID-19 em quatro capitais brasileiras e sua possível relação temporal com a variante Gama, 2020-2021. Epidemiol Serv Saude. 2021;30(1):e2021709.
6. Zhang W, Du RH, Sun R, Yang R, Zhang XE. Recent advances of functional nucleic acid-based sensors for point-of-care detection of SARS-CoV-2. Microchim Acta. 2022;189(3):128.
7. Chen Y, Yang W, Chen F, Cui L. COVID-19 and cognitive impairment: Neuroinvasive and blood-brain barrier dysfunction. J Neuroinflammation. 2022;19(1):222.
8. Golzari-Sorkheh M, Weaver DF, Reed MA. COVID-19 as a risk factor for Alzheimer's disease. J Alzheimers Dis. 2023;91(1):1-23.
9. Yadav T, Kumar S, Mishra G, Saxena SK. Tracking the COVID-19 vaccines: The global landscape. Hum Vaccin Immunother. 2023;19(1):2191577.
10. Davis HE, McCorkell L, Vogel LM, Topol EL. Long COVID: Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-46.
11. Grundmann A, Wu CH, Hardwick M, Baillie JK, Openshaw PJ, Semple MG et al. Fewer COVID-19 neurological complications with dexamethasone and remdesivir. Ann Neurol. 2023;93(1):88-102.
12. Curley GA, Klepe A, Francistiová L, Gulya K, Dinnyés A. Cellular and molecular effects of SARS-CoV-2 linking lung infection to the brain. Front Immunol. 2021;12(1):3248.
13. Savikangas T, Törmäkangas T, Tirkkonen A, Alen M, Fielding RA, Kivipelto M et al. The effects of a physical and cognitive training intervention vs. physical training alone on older adults' physical activity: A randomized controlled trial with extended follow-up during COVID-19. PLoS One. 2021;16(10):e0258559.
14. Quinn KL, Lam GY, Walsh JF, Bhéreur A, Brown AD, Chow CW et al. Cardiovascular considerations in the management of people with suspected long Covid. Can J Cardiol. 2023;39(6):741-53.
15. Muccioli L, Pensato U, Cani I, Guerra L, Provini F, Bordin G et al. COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment. J Neuroimmunol. 2020;349:577400.
16. Kong APH. COVID-19 and aphasia. Curr Neurol Neurosci Rep. 2021;21:1-8.
17. Bryce-Moncloa A, Bryce-Alberti M, Portmann-Baracco A, Urquiaga-Calderón J, Larrauri-Vigna C, Alegría-Valdivia E. COVID-19 from a cardiovascular perspective. Arch Cardiol Mex. 2021;91:86-94.
18. Büttner-Kunert J, Blöchinger S, Falkowska Z, Rieger T, Oslmeier C. Interaction of discourse processing impairments, communicative participation, and verbal executive functions in people with chronic traumatic brain injury. Front Psychol. 2022;13:892216.
19. Coelho CA. Management of discourse deficits following traumatic brain injury: Progress, caveats, and needs. Semin Speech Lang. 2007;28(2):122-35.
20. García JC, Díez E, Wojcik DZ, Santamaría M. Communication support needs in adults with intellectual disabilities and its relation to quality of life. Int J Environ Res Public Health. 2020;17(20):7370.
21. Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31.
22. Kweon OJ, Kim HR, Lee MK, Lim YK. Real-world accuracy of a SARS-CoV-2 rapid diagnostic tests in the Republic of Korea. J Korean Med Sci. 2022;37(43):e320.
23. Spedo CT, Pereira DA, Foss MP, Barreira AA. Adaptação brasileira do Mini-Mental State Examination: guia portátil e tabela de normas. São Paulo: Hogrefe; 2018.
24. Pawlowski J, Remor E, de Salles JF, Parente MADMP, Fonseca RP, Bandeira DR. Evidência de validade de construto do NEUPSILIN utilizando análise fatorial confirmatória. Actualidades en Psicol. 2014;28(117):37-52.
25. Marquete VF, Chaves TA, Barreto SDS. The effectiveness of speech therapy at the discourse level: Case study of language-cognitive disorder in dementia. CoDAS. 2021;33(2):e20200023.
26. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Routledge; 2013.
27. Ceban F, Ling S, Lui LM, Lee Y, Gill H, Teopiz KM et al. Fatigue and cognitive impairment in post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022;101:93-135.
28. Crivelli L, Palmer K, Calandri I, Guekht A, Beghi E, Carroll W et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimer's & Dementia. 2022;18(5):1047-66.
29. Au Yeung SL, Wong THT, He B, Luo S, Kwok KO. Does ACE2 mediate the detrimental effect of exposures related to COVID-19 risk: A Mendelian randomization investigation. J Med Virol. 2023;95(1):e28205.
30. Ng JH, Sun A, Je HS, Tan EK. Unravelling pathophysiology of neurological and psychiatric complications of COVID-19 using brain organoids. Neuroscientist. 2023;29(1):30-40.
31. Oudit GY, Wang K, Viveiros A, Kellner MJ, Penninger JM. Angiotensin-converting enzyme 2-At the heart of the COVID-19 pandemic. Cell. 2023;186(5):906-22.
32. Langton-Frost N, Brodsky MB. Speech-language pathology approaches to neurorehabilitation in acute care during COVID-19: Capitalizing on neuroplasticity. PM&R. 2022;14(2):217-26.
33. Ramage AE. Potential for cognitive communication impairment in COVID-19 survivors: A call to action for speech-language pathologists. Am J Speech Lang Pathol. 2020;29(4):1821-32.
34. Kim BS, Lee MS. Discourse performance and related cognitive function in mild cognitive impairment and dementia: A preliminary study. Appl Neuropsychol Adult. 2023;30(2):194-203.
35. Henderson A, Kim H, Kintz S, Frisco N, Wright HH. Working memory in aphasia: Considering discourse processing and treatment implications. Semin Speech Lang. 2017;38(1):40-51.
36. Leaman MC, Edmonds LA. Analyzing language in the picnic scene picture and in conversation: The type of discourse sample we choose influences findings in people with aphasia. Am J Speech Lang Pathol. 2023;32(4):1413-30.
37. Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: What do we know in 2023. Pol Arch Intern Med. 2023;16402.
38. Lê K, Coelho C, Feinn R. Contribution of working memory and inferencing to narrative discourse comprehension and production in traumatic brain injury. J Speech Lang Hear Res. 2023;66(7):2346-61.
39. Kleinman D, Morgan AM, Ostrand R, Wittenberg E. Lasting effects of the COVID-19 pandemic on language processing. PLoS One. 2022;17(6):e0269242.
40. Cruice M, Botting N, Marshall J, Boyle M, Hersh D, Pritchard M et al. UK speech and language therapists' views and reported practices of discourse analysis in aphasia rehabilitation. Int J Lang Commun Disord. 2020;55(3):417-42.
Submitted date:
21/05/2025
Accepted date:
18/08/2025
Facebook
Twitter
LinkedIn
Mendeley
Email